Gothere Inc
PO Box 425025
Cambridge MA Massachusetts
United States 02142
Cambridge MA Massachusetts
United States 02142
Phone:
+1 617 699 4036, Fax: +1 571 434 4620
Keywords:
Biomedical Engineering Tissue Engineering
The firm commercializes a family of self-assembling nanoscale scaffolds called PuraMatrix. 3DM’s materials assemble upon injection into nanofibers, serving as a scaffold for tissue regeneration.
3DM INC -- PURAMATRIX SYNTHETIC PEPTIDE HYDROGELS - CELL CULTURE, BIOPRODUCTION, MEDICAL DEVICES 3DM Inc.—Accelerating Regenerative Medicine & Drug Discovery PuraMatrix ™ Synthetic Peptide Hydrogels have been shown to grow cells better than other biomaterials and scaffolds, especially many of the highest value and most sensitive cells—some uncultivable without PuraMatrix . Clinical & pre-clinical research in Regenerative Medicine —due to PuraMatrix's ideal injectability, bioresorbability and gel carrier properties, these hydrogels are currently being used by collaborators in a wide array of in vivo cell therapy and tissue regeneration and drug delivery research initiatives in Orthopedics, Cardiovascular and CNS applications. 3DM can quickly provide materials and protocols for integrating into these types of studies. As recently detailed in Nature, Nature Biotechnology, Circulation, Biomaterials, EMBO , and Tissue Engineering , PuraMatrix may be used to create synthetic self-assembling peptide nanofiber scaffolds and defined 3-D microenvironments, with utility in drug discovery assays, bioproduction, tissue engineering, and cell-based assays including cell migration and invasion, angiogenesis, apoptosis, neurite outgrowth, and hepatocyte functionality and toxicity. Track 3DM Announcements, Articles & Events Name: Institution: Email: Comments, Questions, Requests: Add me to the mailing list 3DM Inc. is a privately-held specialty biomaterials company, with a mission of developing novel medical therapies through its technologies for accelerating wound healing and tissue regeneration across a range of medical indications. 3DM Inc. has commercialized a revolutionary family of self-assembling nano-scale scaffolds, PuraMatrix, which has received numerous awards as a leading commercial synthetic scaffold for 3D cell culture in drug discovery, cancer biology, stem cell research and bioproduction, sold through a worldwide partnership with Becton Dickinson (NYSE: BDX). 3DM’s medical devices provi
